Wei et al. (114) found that circ-CDYL and its target genes (HDGF and HIF1AN) were highly expressed in Barcelona Clinic Liver Cancer (BCLC) stages 0 and A of HCC. This evidence concerns the gene HIF1AN and hepatocellular carcinoma.